---
$id: https://graph.org.ai/products/commodity/51433305
$type: Product
source: UNSPSC
code: "51433305"
title: "Hydralazine hydrochloride"
class: "51433300"
classTitle: "Antihypertensive phthalazines"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Hydralazine hydrochloride

**UNSPSC Code**: 51433305
**Class**: [Antihypertensive phthalazines](Antihypertensive phthalazines.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antihypertensive agent with the molecular formula C8H8N4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FD171B778Y, chemically known as 1 (2h)-phthalazinone, hydrazone, monohydrochloride but more generally known as hydralazine hydrochloride, which bears US NIH Compound Identifier 3637. European Medicines Agency schedules Hydralazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02553MIG. Most nations, for tariff and trade purposes, schedule hydralazine hydrochloride under HS 29339990 and SITC 51577. As of Q4 2014, HYDRALAZINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Hydralazine hydrochloride bears US NLM identifiers UMLS ID C0699178 and NCI Concept Code C551. SMILES: C1CCC2C(C1)CNNC2NN.CL.

